The use of novel YAP-TEAD Hippo pathway inhibitors to target Merlin (NF2) null tumors

syn22268652

Created By Kaitlin Throgmorton kthrog

grantDOI: https://doi.org/10.48105/pc.gr.93158
studyName: The use of novel YAP/TEAD Hippo pathway inhibitors to target Merlin (NF2) null tumors
dataStatus: Under Embargo
initiative: Young Investigator Award
studyLeads: Liyam Laraba
studyStatus: Completed
diseaseFocus: Neurofibromatosis type 2
institutions: University of Plymouth
fundingAgency: CTF
relatedStudies: syn27761862 syn27261816 syn25961160 syn35632706
studyFileviewId: syn22268815
syn22268670
syn22268680
syn22268815
syn22268674

Your web browser must have JavaScript enabled in order for this application to display correctly.
If you are an automated web crawler from a search engine, follow this AJAX application crawl link

The use of novel YAP-TEAD Hippo pathway inhibitors to target Merlin (NF2) null tumors

syn22268652

Drop files to upload

The use of novel YAP-TEAD Hippo pathway inhibitors to target Merlin (NF2) null tumors page is loading…